Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ RNF213 Polyclonal Antibody

Goat Polyclonal Antibody

Supplier:  Invitrogen™ PA5142253

Catalog No. PIPA5142253


Only null left
Add to Cart
This item is not returnable. View return policy

Description

Description

This antibody is tested in Peptide ELISA: antibody detection limit dilution 1:128,000.

RNF213 is an E3 ubiquitin-protein ligase involved in angiogenesis. Involved in the non-canonical Wnt signaling pathway in vascular development: acts by mediating ubiquitination and degradation of FLNA and NFATC2 downstream of RSPO3, leading to inhibit the non-canonical Wnt signaling pathway and promoting vessel regression. Also has ATPase activity.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

RNF213
Polyclonal
Unconjugated
RNF213
6030403J01; ALK lymphoma oligomerization partner on chromosome 17; ALO17; C17orf27; D11Ertd759e; E3 ubiquitin-protein ligase RNF213; KIAA1554; KIAA1618; mKIAA1554; MYMY2; Mysterin; MYSTR; NET57; protein ALO17; RGD1308168; RING finger protein 213; RING-type E3 ubiquitin transferase RNF213; RNF213
Goat
Ammonium sulfate precipitation
RUO
57674
-20°C, Avoid Freeze/Thaw Cycles
Liquid
Immunohistochemistry (Paraffin)
0.5 mg/mL
TBS with 0.5% BSA and 0.02% sodium azide; pH 7.3
Q63HN8
RNF213
Peptide with sequence C-KNPQTQTEERFRPQ.
100 μg
Primary
Human
Antibody
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.